What is the recommended dose of mannitol in mL for a 72 kg adult patient with a massive bleed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mannitol Dosing in mL for a 72 kg Adult with Massive Hemorrhage

For a 72 kg adult with massive hemorrhage, administer 18-36 mL of 25% mannitol (or 90-180 mL of 20% mannitol) intravenously over 20 minutes, which can be repeated every 6 hours as needed, with a maximum total daily dose of 144 g (576 mL of 25% solution or 720 mL of 20% solution).

Standard Dosing Calculation

The recommended dose is 0.25 to 0.5 g/kg body weight administered over 20-30 minutes 1, 2. For a 72 kg patient:

  • Minimum dose: 0.25 g/kg × 72 kg = 18 g
  • Maximum dose: 0.5 g/kg × 72 kg = 36 g

Volume Conversions by Concentration:

For 25% mannitol (250 mg/mL):

  • Minimum: 18 g ÷ 0.25 g/mL = 72 mL
  • Maximum: 36 g ÷ 0.25 g/mL = 144 mL

For 20% mannitol (200 mg/mL):

  • Minimum: 18 g ÷ 0.20 g/mL = 90 mL
  • Maximum: 36 g ÷ 0.20 g/mL = 180 mL

1, 3

Critical Considerations for Massive Hemorrhage

Mannitol should only be used if there are clinical signs of elevated intracranial pressure or impending herniation (declining consciousness, pupillary changes, decerebrate posturing), not routinely in all massive hemorrhage cases 2, 4. In the context of massive hemorrhage without intracranial pathology, mannitol is not indicated and may worsen outcomes by causing osmotic diuresis and exacerbating hypovolemia 5.

If Hemorrhage is Intracranial:

  • Initial bolus: 72-144 mL of 25% mannitol (or 90-180 mL of 20% solution) over 20 minutes 1, 2
  • Repeat dosing: Can be given every 6 hours as needed 1, 2
  • Maximum daily dose: 2 g/kg = 144 g for 72 kg patient = 576 mL of 25% solution or 720 mL of 20% solution 1, 2

Mandatory Monitoring and Discontinuation Criteria

Stop mannitol immediately if:

  • Serum osmolality exceeds 320 mOsm/L 2, 6, 1, 3
  • No clinical improvement after 2-4 doses 6
  • Clinical deterioration despite treatment 6

Monitor every 6 hours:

  • Serum osmolality 4
  • Electrolytes (particularly sodium) 2
  • Neurological status 4
  • Fluid balance 2

Essential Pre-Administration Steps

Before giving mannitol:

  • Insert Foley catheter (mannitol causes profound osmotic diuresis) 3
  • Ensure patient is not severely hypovolemic from the massive bleed 1
  • Confirm clinical signs of elevated ICP or herniation 2, 4
  • Avoid if patient has well-established anuria, severe pulmonary edema, or severe dehydration 1

Important Caveats for Massive Hemorrhage Context

In massive hemorrhage WITHOUT intracranial involvement, focus should be on:

  • Fresh frozen plasma (FFP) at 15-30 mL/kg (1,080-2,160 mL for 72 kg patient) to prevent dilutional coagulopathy 5
  • Maintaining platelet count ≥75 × 10⁹/L 5
  • Maintaining fibrinogen ≥1.5 g/L 5

Mannitol is contraindicated in hypovolemic shock and should never be used as volume replacement in massive hemorrhage 1. If the massive bleed has caused hypovolemia, correct this with crystalloids and blood products first before considering mannitol for any intracranial indication 3.

Alternative Therapy

Hypertonic saline (3% or 23.4%) is an equally effective alternative with potentially longer duration of action and may be safer in hemorrhagic contexts 2, 4, 7. Consider this if mannitol is contraindicated or ineffective.

References

Guideline

Management of Hemorrhagic Stroke with Mannitol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mannitol and other diuretics in severe neurotrauma.

New horizons (Baltimore, Md.), 1995

Guideline

Mannitol Use in Hemorrhagic Stroke

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Mannitol in Hemorrhagic Stroke

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.